Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 References

Naltalimide

Add links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia

Naltalimide
Clinical data

ATC code	None
Identifiers
IUPAC name 2-[(5α,6β)-17-(Cyclopropylmethyl)-3,14-dihydroxy-4,5-epoxymorphinan-6-yl]-1H-isoindole-1,3(2H)-dione
CAS Number	160359-68-2
PubChem CID	16066809
ChemSpider	17226389
UNII	PUO0LMS4NX
CompTox Dashboard (EPA)	DTXSID10166868
Chemical and physical data
Formula	C₂₈H₂₈N₂O₅
Molar mass	472.541 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES c1ccc2c(c1)C(=O)N(C2=O)[C@@H]3CC[C@]4([C@H]5Cc6ccc(c7c6[C@]4([C@H]3O7)CCN5CC8CC8)O)O
InChI InChI=1S/C28H28N2O5/c31-20-8-7-16-13-21-28(34)10-9-19(30-25(32)17-3-1-2-4-18(17)26(30)33)24-27(28,22(16)23(20)35-24)11-12-29(21)14-15-5-6-15/h1-4,7-8,15,19,21,24,31,34H,5-6,9-14H2/t19-,21-,24+,27+,28-/m1/s1 Key:DHAITNWJDOSRBU-IBHWKQIPSA-N

Naltalimide (INN) (code name TRK-130, formerly TAK 363) is a novel, centrally-acting opioid drug which is under development by Takeda and Toray for the treatment of overactive bladder/urinary incontinence.^[1]^[2] It acts as a potent and selective partial agonist of the μ-opioid receptor (K_i = 0.268 nM, EC₅₀ = 2.39 nM, E_max = 66.1%) over the δ-opioid (K_i = 121 nM, EC₅₀ = 26.1 nM, E_max = 71.0%) and κ-opioid receptors (K_i = 8.97 nM, EC₅₀ = 9.51 nM, E_max = 62.6%).^[1] Notably, naltalimide somehow appears to lack certain undesirable side effects such as constipation seen with other μ-opioid receptor agonists such as morphine.^[1] It enhances bladder storage via suppression of the afferent limb of the micturition reflex pathway.^[1]

References[edit]

^ ^a ^b ^c ^d Fujimura M, Izumimoto N, Momen S, Yoshikawa S, Kobayashi R, Kanie S, et al. (September 2014). "Characteristics of TRK-130 (Naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder". The Journal of Pharmacology and Experimental Therapeutics. 350 (3): 543–51. doi:10.1124/jpet.114.214031. PMID 24928951. S2CID 2238176.